ArticleBlood advances2024

Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma.

Giuseppe Gritti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.